Your browser doesn't support javascript.
loading
Evaluation of IgE Antibodies to Omalizumab (Xolair®) and Their Potential Correlation to Anaphylaxis.
Baker, Dana L; Nakamura, Gerald R; Lowman, Henry B; Fischer, Saloumeh Kadkhodayan.
Afiliação
  • Baker DL; Department of Assay Development and Technology, Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA.
  • Nakamura GR; Department of Assay Development and Technology, Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA.
  • Lowman HB; Department of Assay Development and Technology, Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA.
  • Fischer SK; Department of Assay Development and Technology, Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA. fischer.sally@gene.com.
AAPS J ; 18(1): 115-23, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26340860
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Antialérgicos / Omalizumab / Anafilaxia / Anticorpos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Antialérgicos / Omalizumab / Anafilaxia / Anticorpos Idioma: En Ano de publicação: 2016 Tipo de documento: Article